secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2026-06-16T20:05:35+00:00
Accession:  0001104659-26-074575
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune plans HQ move from Gaithersburg, MD to Morristown, NJ
---------------------------------------------------------------

- Announced on June 16, 2026, relocation expected later this year.
- New 5-year lease with annual rent of approximately $300,000.
- Move to biopharma hub in NJ to support talent attraction in hybrid model.
- Company expects long-term cost efficiencies from the relocation.
- Headquarters change from 910 Clopper Road, Gaithersburg to Morristown.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000110465926074575/0001104659-26-074575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000110465926074575/tm2618087d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-074575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer